Hao Feng

Deputy director of Clinical Research Unit/ Section leader of Dept. Liver Surg(Award V)
Renji Hosp., Shanghai JiaoTong Univ. Sch. of Med., China (People's Republic)

Poster(s):

• (859) The FOCUS19 study: Efficacy of an oral PD-L1 inhibitor combined with an oral FGF19 in advanced hepatocellular carcinoma after 1st+ line treatment
  Friday, April 17, 2026

  11:30 AM - 12:30 PM US ET